Consonance

Consonance collaborates with ambitious start-ups, dynamic SMEs, and renowned international pharmaceutical companies to jointly create innovative medical solutions. As an ISO 13485:2016 certified company in the area of medical device design, development, and manufacturing, Consonance ensures that their medical products meet MDR and FDA regulatory standards. Their dedication to quality and efficiency has led to the launch of 3 medical innovations into production in 2023. The company's achievements include winning 1st and 2nd place in the Huawei Startup Challenge and receiving honorable mentions in the Mother & Child Startup Challenge, organized by the Institute of Mother and Child in Warsaw.

The last investment in Consonance was a Seed Round investment at 15 December 2016 by RTA.vc. Consonance's focus on innovation and regulatory compliance, coupled with its proven track record, positions the company as a promising player in the Health Care and Medical Devices industries. With its impactful mission and successful partnerships, Consonance has the potential to change the future of healthcare.